• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Thyroid Autoimmunity Does Not Raise Embryo Aneuploidy Risk in IVF Patients

by
November 7, 2026
in Health
Reading Time: 3 mins read
0
Thyroid Autoimmunity Does Not Raise Embryo Aneuploidy Risk in IVF Patients

Thyroid Autoimmunity Does Not Raise Embryo Aneuploidy Risk in IVF Patients

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Women with recurrent pregnancy loss or advanced maternal age who carry thyroid antibodies can take some reassurance from a new study: their embryos appear no more likely to be chromosomally abnormal than those of women with healthy thyroid glands.

The study focused on two groups of patients undergoing in vitro fertilization who face elevated reproductive risks: women with recurrent pregnancy loss, defined as repeated miscarriages, and women of advanced maternal age. Both groups underwent preimplantation genetic testing for aneuploidy, or PGT-A, a laboratory technique that screens embryos for missing or extra chromosomes before they are transferred to the uterus.

Researchers divided the participants into comparison groups based on thyroid status. One set of comparisons separated women with thyroid autoimmunity, in which the immune system produces antibodies that attack the thyroid gland, from women without such antibodies. A second set separated women with overt hypothyroidism from women whose thyroid function was normal. The investigators then measured euploidy rates—the proportion of blastocysts, or day-five to day-seven embryos, that tested chromosomally normal—and tracked the outcomes of transfers that used only euploid embryos.

The results on embryo quality were strikingly consistent. Blastocyst euploidy rates did not differ significantly between the thyroid autoimmunity group and the non-autoimmune group. The same held true for overt hypothyroidism: euploidy rates in that group were statistically indistinguishable from those in women with normal thyroid function. In other words, neither the presence of thyroid antibodies nor a severely underactive thyroid appeared to make embryos more likely to carry chromosomal errors, at least in this population of women already undergoing genetic screening of their embryos.

Transfer outcomes told a similar story for autoimmunity. When only chromosomally normal embryos were transferred, women with thyroid autoimmunity achieved clinical pregnancy and live birth rates comparable to those of women without it, with no statistically significant differences in any measured outcome. The study’s conclusion was direct: thyroid autoimmunity might not have adverse effects on euploid embryo transfer outcomes among women with recurrent pregnancy loss and advanced maternal age.

Overt hypothyroidism presented a more nuanced picture. Among women with recurrent pregnancy loss, the clinical pregnancy rate and live birth rate per euploid embryo transfer were both lower in the hypothyroid group than in the normal thyroid function group, and the miscarriage rate was higher. The study’s authors characterized overt hypothyroidism as potentially having slightly adverse effects on euploid embryo transfer outcomes in patients with recurrent pregnancy loss, a cautious formulation that acknowledges the direction of the observed differences without overstating their certainty.

Where overt hypothyroidism did show statistically significant effects was in pregnancy-related complications and newborn characteristics. Among women with recurrent pregnancy loss, the incidence of pregnancy-related complications was significantly greater in the overt hypothyroidism group than in the normal thyroid function group. Among women of advanced maternal age, the body weights of newborns were significantly lower in the overt hypothyroidism group.

The study’s design deserves attention when interpreting these results. Because all participants underwent PGT-A, the researchers could separate the question of embryo chromosome status from the question of whether a pregnancy, once established with a normal embryo, progresses successfully.

Thyroid autoimmunity, in the absence of overt thyroid dysfunction, does not appear to compromise embryo chromosomal normality or the success of euploid embryo transfer in this population. Overt hypothyroidism, meanwhile, did not appear to increase aneuploidy risk but was associated with significantly higher rates of pregnancy complications among women with recurrent pregnancy loss and significantly lower newborn birth weights among women of advanced maternal age.

Subject of Research: Effects of overt hypothyroidism and thyroid autoimmunity on embryo aneuploidy risk and pregnancy outcomes after euploid embryo transfer in women with recurrent pregnancy loss and advanced maternal age

Article Title: Effects of overt hypothyroidism and thyroid autoimmunity on the risk of embryo aneuploidy and pregnancy outcomes resulting from euploid embryo transfer

Article References: Leng, M., Zhang, L., Liu, C., Wang, J., Jin, J., Luan, Y., Zhang, J., & Guan, Y. (2026). Effects of overt hypothyroidism and thyroid autoimmunity on the risk of embryo aneuploidy and pregnancy outcomes resulting from euploid embryo transfer. BMC Pregnancy and Childbirth. https://doi.org/10.1186/s12884-026-10129-w

Image Credits: AI Generated

DOI: 10.1186/s12884-026-10129-w

Keywords: thyroid autoimmunity, overt hypothyroidism, embryo aneuploidy, euploid embryo transfer, recurrent pregnancy loss, advanced maternal age, PGT-A, IVF, blastocyst euploidy, pregnancy complications, live birth rate, miscarriage

News Source: Ophelia Keating. (November 7, 2026). Thyroid Autoimmunity Does Not Raise Embryo Aneuploidy Risk in IVF Patients. Scienmag.

Tags: advanced maternal ageblastocyst euploidyembryo aneuploidyeuploid embryo transferIVFlive birth ratemiscarriageovert hypothyroidismPGT-Apregnancy complicationsRecurrent Pregnancy Lossthyroid autoimmunity
Share12Tweet7Share2ShareShareShare1

Related Posts

Meta-Analysis Identifies Four Causal Risk Factors for Bladder Cancer

Meta-Analysis Identifies Four Causal Risk Factors for Bladder Cancer

November 18, 2026
Inhibiting Toll-like Receptor 2 Reduces Age-Related Pancreatic Islet Inflammation and Fibrosis

Inhibiting Toll-like Receptor 2 Reduces Age-Related Pancreatic Islet Inflammation and Fibrosis

November 18, 2026

Spain NTD Drug Study Reveals Severe Territorial Gaps Across Autonomous Communities

November 18, 2026

Guinea Health Study Reveals Severe Workforce Unemployment Despite Rising Professional Training

November 18, 2026

POPULAR NEWS

  • Spain NTD Drug Study Reveals Severe Territorial Gaps Across Autonomous Communities

    Spain NTD Drug Study Reveals Severe Territorial Gaps Across Autonomous Communities

    29 shares
    Share 12 Tweet 7
  • Guinea Health Study Reveals Severe Workforce Unemployment Despite Rising Professional Training

    29 shares
    Share 12 Tweet 7
  • Rootstock Signaling Networks Dynamically Reprogram Fruit Quality Across Horticultural Crops

    29 shares
    Share 12 Tweet 7
  • Review Uncovers How Group 2 Innate Lymphoid Cells Bridge Neuroimmune Communication

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Meta-Analysis Identifies Four Causal Risk Factors for Bladder Cancer

Inhibiting Toll-like Receptor 2 Reduces Age-Related Pancreatic Islet Inflammation and Fibrosis

Spain NTD Drug Study Reveals Severe Territorial Gaps Across Autonomous Communities

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.